Menu Close

What does an octreotide scan show?

What does an octreotide scan show?

An octreotide scan is used to detect and monitor treatment of neuroendocrine tumours, which arise from cells that produce hormones that are carried in the bloodstream. Many of these tumours are benign (non-cancerous), but some are malignant and can spread around the body.

What is Pentetreotide scintigraphy?

In pentetreotide (OctreoScan, Mallinckrodt Medical) is a somatostatin analog that targets a variety of neuroendocrine tumors including carcinoid tumors, pancreatic islet cell neoplasm, gastrinoma, pheochromocytoma, neuroblastoma, and paraganglioma. Whole body planar and SPECT imaging are performed at 4 and 24 hours.

What is NM OctreoScan?

What is an Octreoscan (Octreotide) study? An Octreotide study is a diagnostic study done in Nuclear Medicine. It involves an injection of a radioactive material called a radiotracer. The radiotracer, called Indium-111 Octreotide (111In-Pentreotide), attaches to the Somatostatin receptors of certain tumors.

How are neuroendocrine tumors diagnosed?

Your doctor may recommend testing your blood or your urine for signs of excess hormones that are sometimes produced by neuroendocrine tumors. Imaging tests. You might undergo imaging tests, such as ultrasound, CT and MRI , to create pictures of your tumor.

How does somatostatin receptor scintigraphy work?

A type of radionuclide scan used to find carcinoid and other types of tumors. Radioactive octreotide, a drug similar to somatostatin, is injected into a vein and travels through the bloodstream. The radioactive octreotide attaches to tumor cells that have receptors for somatostatin.

How long does an Octreoscan take?

This scan takes about 20 minutes. These images will be shown to the radiologist and the radiologist will determine if another set of images is needed on this day. If needed, the technologist will take another set of images called a SPECT/CT.

What is the difference between a PET scan and an octreotide scan?

Conclusions Ga PET/CT is more accurate for staging and superior to Octreoscan SPECT in the detection of overall number of lesions in the body as well as organs and bones. Ga PET/CT also allows for calculation of standardized uptake value, has less whole body radiation, and is performed in less time versus Octreoscan.

How accurate is octreotide scan?

Octreotide scans are reported to have a sensitivity between 75 percent and 100 percent for detecting pancreatic neuroendocrine tumors.

How is indium 111 produced?

Indium-111 is produced in a cyclotron using a cadmium-112 target which is bombarded with protons to produce indium-111 by the (p,2n) reaction. The energies of the γ-ray emissions (171 and 245 keV) are higher than that of technetium-99m. Indium-111 forms complexes in which indium is present in the + 3 oxidation state.

Do carcinoid tumors show on PET scan?

Typical positron emission tomography (PET) scans are not effective in detecting carcinoid tumors, because unlike other cancers, NETs do not consume glucose rapidly.

What is 111 octreotide scintigraphy?

Octreotide scintigraphy. Octreotide scintigraphy uses 111 In-labeled octreotide which is a somatostatin analog; it is also known as an Octreoscan TM, a brand name for 111 In-labeled pentetreotide; pentetreotide is a DTPA-conjugated form of octreotide, originally manufactured by Mallinckrodt Nuclear Medicine LLC,…

What is 111indium–pentetreotide scintigraphy (SRS)?

Open in a separate window 111Indium–pentetreotide scintigraphy (SRS) identified foci of disease not seen on cross-sectional imaging in just 8 (11 %) of 74 of the cohort with biochemical evidence of neuroendocrine disease, and 111indium–pentetreotide scintigraphy altered the surgical management of only 3 (4 %) of 74 of this cohort

What are the possible causes of octreotide scintigraphy in head and neck lesions?

Also, certain autoimmune or granulomatous diseases (for example sarcoidosis) may occasionally show octreotide uptake by overexpression of somatostatin receptors 6-8. 1. Whiteman ML, Serafini AN, Telischi FF et-al. 111In octreotide scintigraphy in the evaluation of head and neck lesions.